SLC25A13 and metabolic dysfunction-associated steatohepatitis: Patients with Citrin deficiency or adult-onset type II citrullinemia are prone to fatty liver, non-alcoholic steatohepatitis (NASH), and even hepatocellular carcinoma (37).